{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004235757503232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1872-034x.2012.00992.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2012.00992.x"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2012.00992.x"}},{"identifier":{"@type":"PMID","@value":"22882336"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"First two cases of adult‐onset type II citrullinemia successfully treated by deceased‐donor liver transplantation in Japan"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>We report the first two cases of adult‐onset type II citrullinemia (CTLN2) successfully treated by liver transplantation from deceased donors in Japan. One patient was a 34‐year‐old female, who had suffered from depression since the age of 28 years and developed consciousness disturbance at 34 years old. The other patient was a 41‐year‐old man who began to experience consciousness disturbance with abnormal behavior at 37 years old. Both patients were first treated with non‐surgical therapies, including low‐carbohydrate diet, arginine granules and sodium pyruvate. However, their therapeutic efficacy was limited and attacks of encephalopathy occurred frequently with elevation of plasma ammonia despite treatment. While both patients and their families desired liver transplantation, no candidate donors for live‐donor liver transplantation were available. Fortunately, within a relatively short period after enrollment for liver transplant from deceased donors in Japan (13 and 43 days, respectively), they underwent cadaveric liver transplantation. The clinical courses after the operation were uneventful in both cases and no attacks of hepatic encephalopathy have occurred. Although there have been no reports of good therapies for CTLN2 patients with resistance to non‐surgical therapies and no live‐donor candidates, our observations indicate that cadaveric liver transplantation can be a promising therapeutic option for CTLN2 patients.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420001326212727680","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"70372513"},{"@type":"NRID","@value":"1000070372513"},{"@type":"NRID","@value":"9000001488771"},{"@type":"NRID","@value":"9000412637331"},{"@type":"NRID","@value":"9000001476585"},{"@type":"NRID","@value":"9000413473725"},{"@type":"NRID","@value":"9000411811732"},{"@type":"NRID","@value":"9000351078783"},{"@type":"NRID","@value":"9000022065069"},{"@type":"NRID","@value":"9000001488829"},{"@type":"NRID","@value":"9000021888792"},{"@type":"NRID","@value":"9000021432692"},{"@type":"NRID","@value":"9000379610229"},{"@type":"NRID","@value":"9000001476797"},{"@type":"NRID","@value":"9000261675994"},{"@type":"NRID","@value":"9000412604346"},{"@type":"NRID","@value":"9000257859516"},{"@type":"NRID","@value":"9000020737093"},{"@type":"NRID","@value":"9000242155161"},{"@type":"NRID","@value":"9000021925488"},{"@type":"NRID","@value":"9000021330096"},{"@type":"NRID","@value":"9000411515084"},{"@type":"NRID","@value":"9000415323665"},{"@type":"NRID","@value":"9000402771823"},{"@type":"NRID","@value":"9000021889627"},{"@type":"NRID","@value":"9000412320118"},{"@type":"NRID","@value":"9000412601804"},{"@type":"NRID","@value":"9000412604114"},{"@type":"NRID","@value":"9000000562281"},{"@type":"NRID","@value":"9000240524982"},{"@type":"NRID","@value":"9000020284922"},{"@type":"NRID","@value":"9000021405931"},{"@type":"NRID","@value":"9000409987637"},{"@type":"NRID","@value":"9000259296279"},{"@type":"NRID","@value":"9000021490239"},{"@type":"NRID","@value":"9000411514321"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0116212"}],"foaf:name":[{"@value":"Masahide Yazaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503365","@type":"Researcher","foaf:name":[{"@value":"Akiyo Hineno"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503236","@type":"Researcher","foaf:name":[{"@value":"Akira Matsushima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503232","@type":"Researcher","foaf:name":[{"@value":"Kazuki Ozawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503244","@type":"Researcher","foaf:name":[{"@value":"Dai Kishida"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016864301436672","@type":"Researcher","foaf:name":[{"@value":"Ko‐ichi Tazawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503248","@type":"Researcher","foaf:name":[{"@value":"Kazuhiro Fukushima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503239","@type":"Researcher","foaf:name":[{"@value":"Koichi Urata"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503366","@type":"Researcher","foaf:name":[{"@value":"Toshihiko Ikegami"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235757503249","@type":"Researcher","foaf:name":[{"@value":"Shinichi Miyagawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016864301436673","@type":"Researcher","foaf:name":[{"@value":"Shu‐ichi Ikeda"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13866346"},{"@type":"EISSN","@value":"1872034X"}],"prism:publicationName":[{"@value":"Hepatology Research"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2012-08-09","prism:volume":"42","prism:number":"9","prism:startingPage":"934","prism:endingPage":"939"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2012.00992.x"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2012.00992.x"}],"createdAt":"2012-08-10","modifiedAt":"2025-04-06","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782123644928","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22590332"},{"@type":"JGN","@value":"JP22590332"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22590332/"}],"notation":[{"@language":"ja","@value":"肝移植後 FAP 患者のアミロイド線維融解機序の解明"},{"@language":"en","@value":"A study of the pathomechanism of amyloid fibril turnover in FAP patients after liver transplantation"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360586669069746688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Orthotopic liver transplantation for adult‐onset Type II citrullinaemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570527652736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Treatment of a citrin‐deficient patient at the early stage of adult‐onset type II citrullinaemia with arginine and sodium pyruvate"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519773817088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Model for end-stage liver disease (MELD) and allocation of donor livers"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520150657024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Orthotopic liver transplantation for urea cycle enzyme deficiency"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996327427584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Citrin Deficiency: A Novel Cause of Failure to Thrive That Responds to a High-Protein, Low-Carbohydrate Diet"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468744510464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944013280128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"First case of cadaveric liver transplantation in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419746341632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"COMPLETE NEUROLOGICAL RECOVERY OF AN ADULT PATIENT WITH TYPE II CITRULLINEMIA AFTER LIVING RELATED PARTIAL LIVER TRANSPLANTATION1"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844141924608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320291695232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320773712128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793365156992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1370004235757503234","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Current status and future of cadaveric liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206326390400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Characteristics of Food Intake in Patients with Type II Citrullinemia"},{"@value":"The characteristics of food intake in patients with type 2 citrullinemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447408384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"7. Liver Transplanation for Hereditary Diseases"},{"@language":"ja","@value":"7．遺伝病と肝移植"},{"@value":"遺伝病と肝移植"},{"@language":"ja-Kana","@value":"イデンビョウ ト カン イショク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847185280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Conventional Diet Therapy for Hyperammonemia is Risky in the Treatment of Hepatic Encephalopathy Associated with Citrin Deficiency"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2012.00992.x"},{"@type":"KAKEN","@value":"PRODUCT-13528285"},{"@type":"OPENAIRE","@value":"doi_dedup___::4bc9c9eb186cfebac7672a4e5937d6cf"},{"@type":"CROSSREF","@value":"10.2169/naika.102.582_references_DOI_U3x4jy5CtWo5FweHxnT0s6FapO7"}]}